All In Biotech

Drug Trial Radar · NCT03006237

IS-001 Injection Phase-1 Safety, Tolerance and Pharmacokinetics

A Phase 1 Open Label Single Center Safety, Tolerability and Pharmacokinetic Study of IS-001 Injection in Patients Undergoing Robotic Hysterectomy Using the da Vinci® Si/Xi Surgical System With Firefly® Fluorescent Imaging

Last checked: Nov 19, 2026Latest source record: Mar 5, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

24

Actual

Start

Dec 2016

Primary completion

Dec 2017

Study completion Dec 2017

Sponsor

Lead sponsor
Intuitive SurgicalIndustry
Sponsor type
Industry
First posted
Dec 30, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
Female only, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A Phase 1 Open Label Single Center Safety, Tolerability and Pharmacokinetic Study of IS-001

Conditions

  • Hysterectomy
  • Surgery

Interventions

  • IS-001Drug

    10mg, 20mg or 40 mg IV IS-001 drug administered during surgery

  • da Vinci® Si/Xi Surgical SystemDevice

    robot-assisted minimally invasive hysterectomy surgery performed with da Vinci® Si/Xi Surgical System with Firefly® Fluorescent Imaging

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Monitor Safety Parameters (vital signs, ECG, serum chemistry and hematology, urinalysis and adverse events)Time frame: 14 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Las Palmas Medical Center

    El Paso, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.